SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-08-014408
Filing Date
2008-11-05
Accepted
2008-11-05 07:18:34
Documents
6
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y72322e10vq.htm 10-Q 491271
2 EX-10.3: SECOND AMENDMENT TO LEASE y72322exv10w3.htm EX-10.3 30740
3 EX-12.1: STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO COMBINED FIXED CHARGE y72322exv12w1.htm EX-12.1 19257
4 EX-31.1: CERTIFICATION y72322exv31w1.htm EX-31.1 8483
5 EX-31.2: CERTIFICATION y72322exv31w2.htm EX-31.2 8818
6 EX-32: CERTIFICATION y72322exv32.htm EX-32 4028
  Complete submission text file 0000950123-08-014408.txt   563900
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19034 | Film No.: 081162350
SIC: 2834 Pharmaceutical Preparations